MSHNX
Price
$13.18
Change
+$0.13 (+1.00%)
Updated
May 9 closing price
Net Assets
4.81M
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

MSHNX vs RGAHX

Header iconMSHNX vs RGAHX Comparison
Open Charts MSHNX vs RGAHXBanner chart's image
Morgan Stanley Inst Permanence A
Price$13.18
Change+$0.13 (+1.00%)
VolumeN/A
Net Assets4.81M
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
MSHNX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSHNX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSHNX is a Sell and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. MSHNX (4.82M). MSHNX pays higher dividends than RGAHX: MSHNX (2.27) vs RGAHX (0.54). MSHNX was incepted earlier than RGAHX: MSHNX (5 years) vs RGAHX (9 years). MSHNX (8.09) is less costly to investors than RGAHX (0.44). MSHNX is a more actively managed with annual turnover of: 74.00 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than MSHNX: RGAHX (250) vs MSHNX (1000). RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. MSHNX (1.59). RGAHX return over 5 years is better than : 44.87 vs. MSHNX (17.13).
MSHNXRGAHXMSHNX / RGAHX
Total Expense Ratio1.200.44273%
Annual Report Gross Expense Ratio8.090.441,839%
Fund Existence5 years9 years-
Gain YTD4.686-2.478-189%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.82M285B0%
Annual Yield % from dividends2.270.54417%
Returns for 1 year1.593.2549%
Returns for 3 years26.2533.4079%
Returns for 5 years17.1344.8738%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics